Kendle in the red despite trade growth
Despite posting a healthy growth in trade, Kendle slid into the red during its 2006 fourth quarter.
Archives for February 22, 2007
India's Syschem splashes out on plant expansion
Indian chemical firm Syschem is planning to splash out up to $15m (€11.4m) over two years to expand its manufacturing capacity – a move the company said will facilitate its smooth entry into the pharma industry and help cope with expected domestic demand.
Smopex scavenges for metal
Johnson Matthey's metal scavenging system, Smopex, is designed to remove precious metals at high speed from solutions and active pharmaceutical ingredients (APIs).
AZ's Macclesfield site first on the chopping block
AstraZeneca has this week announced 700 job losses the firm's Macclesfield site in the UK. Representing over a quarter of the site's workforce, the cuts come as part of the rationalisation plan announced by the firm at the beginning of the month.
GlaxoSmithKline watches your weight
GlaxoSmithKline (GSK) has acquired licensing rights outside the US to the over the counter (OTC) weight-loss medication orlistat, previously marketed by Roche.
Dyax and Genzyme agrees to terminate DX-88 contract
Dyax announced that it has reached a mutual agreement with Genzyme to terminate their joint venture for the development and commercialization of DX-88 for hereditary angioedema (HAE).